Alessandro Riva founded Cancer International Research Group and Breast Cancer International Research Group Ltd. Currently, Dr. Riva holds the position of Chief Executive Officer for Intima Bioscience, Inc. and Non-Executive Chairman of Transgene SA.

He is also on the board of BeiGene Ltd. and Century Therapeutics, Inc.

In his past career he was Director at Ichnos Sciences, Inc., Executive VP-Oncology Therapeutics at Gilead Sciences, Inc., VP, Head-Oncology Development & Medical Affairs at Novartis AG President for Novartis Oncology, Inc. and EVP, Head-Oncology Development & Medical Affairs at Novartis Pharmaceuticals Corp. (both are subsidiaries of Novartis AG) and Chief Executive Officer-Innovation Business at Glenmark Pharmaceuticals Ltd.

Alessandro Riva received a doctorate from the University of Milan.